Cast OFF Trial: One Versus Four-five Weeks of Plaster Cast Immobilization
NCT ID: NCT03240471
Last Updated: 2021-01-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2017-10-01
2020-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In the Dutch guideline for DRF the treatment advice for DRF, without reduction, is treatment with plaster cast or brace for one-three weeks. Despite the advice in the guideline and despite several studies from the 90's showing that plaster cast treatment of a stable DRF for one week is safe, the usual length of plaster cast treatment for stable DRF is four-six weeks. In addition, recent studies have also shown that a long period of immobilization can lead to more post traumatic pain by increasing disuse and kinesiophobia.
This evidence suggests that the usual duration (4-6 weeks) of plaster cast treatment for DRF is unnecessary.
The aim of this feasibility study is to define whether one week of plaster cast treatment is possible and can lead to better functional results, with at least the same patient satisfaction and complications. In addition, this feasibility study will be used to define the sample size of the future RCT.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Three Weeks of Cast Immobilisation Versus One Week of Brace Immobilisation in Distal Radius Fractures
NCT06235957
Below-elbow or Above-elbow Cast for Extra-articular Distal Radius Fractures
NCT04062110
Long Arm Vs Short Arm Fiberglass Cast for Treatment of Displaced Distal Radius Fractures
NCT03835065
Comparing Forearm and Upper Arm Combi Cast for Distal Forearm Fractures in Children
NCT03297047
Timing of Bridge Plate Removal and Distal Radius Fracture Outcomes
NCT05578612
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
One week of plaster cast
One week of plaster cast after a non-reduced distal radius fracture.
One week of plaster cast
One week of plaster cast as treatment for a non-reduced distal radius fracture.
Control; four-five weeks of plaster cast
Four-five weeks of plaster cast after a non-reduced distal radius fracture, usual care.
Four-Five weeks of plaster cast
Four-Five weeks of plaster cast as treatment for a non-reduced distal radius fracture.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
One week of plaster cast
One week of plaster cast as treatment for a non-reduced distal radius fracture.
Four-Five weeks of plaster cast
Four-Five weeks of plaster cast as treatment for a non-reduced distal radius fracture.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Isolated acute distal radius fracture
* Closed reduction is not performed
* Non-operative treatment with cast immobilisation
* Understanding of Dutch language
Exclusion Criteria
* Multiple injured patient
* Reduction is indicated/performed
* Operative treatment
* Not understanding of Dutch language
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Radboud University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
JP Frolke, Dr.
Role: PRINCIPAL_INVESTIGATOR
Radboud University Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rijnstate hospital
Arnhem, , Netherlands
Ziekenhuis Gelderse Vallei
Ede, , Netherlands
Radboudumc
Nijmegen, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL 59217.091.17
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.